KODIAC LAB · RESEARCH USE ONLY · IN PRIVATE BETA

An analytical workbench for investigators working with research compounds.

Peer-level pharmacology depth. Your private literature, indexed and cited. Compound profiles, stack analysis, COA tracking, vendor records, and daily protocol logging in one connected research environment. Built by Kodiac, for the researchers Kodiac was built for.

Existing Kodiac customers get first access. Use the email on your order to skip the queue.

ACCESS

Three tiers, scaled to the work.

Anonymous visitors get a small daily preview. Subscribers get monthly quotas tied to their account and run Claude Opus 4.8. Heavy mode (Claude Opus 4.8 at maximum reasoning effort) is reserved for the Lab and Heavy tiers.

Free preview

$0 / no signup

Try the workbench before subscribing.

  • 3 chats per day per IP
  • Light and Normal mode only
  • No Heavy mode access
  • No Opus-grade depth
  • Resets every UTC midnight
Open Kodiac Lab

Bench

$10 / month

Entry tier for casual research questions.

  • 100 chats per month
  • Light and Normal mode
  • Normal mode runs Claude Opus 4.8
  • No Heavy mode access
  • Compound mechanism, PK, sourcing
  • Citations to primary literature
Get Bench

Heavy

$100 / month

For deep multi-compound research programs.

  • 2000 chats per month
  • Light, Normal, and Heavy mode
  • Claude Opus 4.8 on Normal and Heavy
  • Up to 200 Heavy-mode chats
  • Priority routing during high load
  • First access to new modes
Get Heavy

Each tier covers one calendar month of access. Quotas reset on the first of each month UTC.Sign in to keep your usage tied to your account.

01 · DEPTH ON DEMAND

Three modes calibrated to the question.

LIGHT

Quick consult.

Concise and direct. Skip mechanism deep-dives unless explicitly asked. One to three short paragraphs or a brief structured answer. Quick reference work and fast consults.

MAX OUTPUT · 1500 TOKENS
NORMAL

Default working mode.

Default working mode. Mechanism and reasoning when it informs the answer. Cites compounds, doses, half-lives, and receptor targets when relevant. The everyday research consult.

MAX OUTPUT · 6000 TOKENS
HEAVY

Exhaustive treatment.

Exhaustive. Full mechanistic treatment with receptor subtype specificity, dose-response data, PK and PD considerations, half-life, and stack interactions. Mines non-English literature where relevant: Russian peptide bioregulator work, Chinese pharmacology, Japanese neuroscience. Surfaces obscure and orphan compounds in the same class. Cites primary sources. Treats the user as a peer-level analyst.

MAX OUTPUT · 16000 TOKENS · MAX EFFORT
02 · YOUR LITERATURE, INDEXED

Every answer cited to your library.

Upload your research literature once. PDFs, DOCX, TXT, Markdown, images. The library ingests, parses, chunks, and embeds every file. Hybrid retrieval combines vector similarity with keyword matching across your entire corpus. Every assistant answer cites the exact source document and page so you can verify the claim against the primary source it came from.

03 · ATTACH PER MESSAGE

Drop a file into the conversation.

Per-message uploads via a paperclip in the input bar. PDF, DOCX, TXT, Markdown, PNG, JPG, JPEG. Multi-file selection. Uploaded files appear as chips above the textarea with filename, size, and a remove control. Files are ephemeral by default. Promote any attachment to your persistent library with one click.

04 · IN-CONTEXT CONTROLS

Switch behavior without leaving the conversation.

A sliders-icon dropdown next to the input bar controls per-message behavior. Switch Research Effort modes. Send the previous assistant turn to a structured note. Apply a saved prompt persona for the next message or the rest of the conversation. Toggle library retrieval on or off for the next message.

05 · STRUCTURED NOTES

Capture the answer, not just the conversation.

Send any assistant turn to Notes. The system extracts a title, a 2 to 4 sentence summary, full content, source conversation link, compound tags, and timestamps. Notes are embedded for retrieval, so they surface in chat the same way library files do. Cross-linked to the compounds they discuss.

06 · COMPOUND PROFILES

An auto-generated reference page for every compound in your library.

Every compound that has ever been tagged in your library or notes gets its own profile page. The system synthesizes a summary from every chunk in your corpus tagged with that compound: mechanism, half-life, literature dose window, receptor targets, common references, sourcing notes. Manual notes section for your own annotations. Linked sources, linked notes, sourcing records, and full COA history. Names are normalized so BPC-157, bpc157, and BPC 157 collapse to one entry.

07 · STACK ANALYSIS

Pick two or more compounds. See the interactions.

Select compounds from your library. The system pulls relevant retrieval chunks for each one, runs an interaction analysis across them, and surfaces synergies, redundancies, contraindications, and pharmacokinetic conflicts. Every claim cites the source document the conclusion came from.

08 · COA TRACKING

Upload a COA. Get structured comparison.

Upload a Certificate of Analysis PDF. The system extracts purity percentage, identity confirmation, flags, analyst, date, and batch identifier. Linked to the relevant compound. Builds a COA history per compound so you can compare batches over time. The file itself goes through the standard library ingestion pipeline so it is also retrievable in chat.

09 · VENDOR RECORDS

Source intelligence in one ledger.

Structured records for raw-powder, packaging, equipment, and analytical vendors. Per-vendor metadata: website, contact methods, lead time, payment methods, quality tier. Quote history. Order history with QC outcomes. Attached COA records. Free-text notes. The institutional memory of your supply chain.

10 · DAILY LOGS

Log it once. Query it forever.

Calendar-view daily logs with structured fields: compounds taken with dose, unit, and timing. Subjective notes. Mood and sleep quality. Training load. Free text. Every entry is embedded on save. A natural-language query bar lets you ask questions like "what was my mood the week I added 9-Me-BC" and the system retrieves relevant entries by semantic similarity and date range.

11 · PERSONAS

Save the prompts you keep rewriting.

Saved prompt personas with optional default Research Effort, default library setting, and default compound tags. Apply a persona for a single message or the rest of the conversation. Build the prompts that match the kind of work you do, and stop typing them again.

12 · DIFF VIEW

Two of anything, side by side.

Compare any two of: compounds, stacks, vendor quotes, notes, protocol log entries. Side-by-side rendering with an LLM-generated key-differences summary at the top. Useful when you cannot remember why one stack worked and the other did not.

WHAT IT LOOKS LIKE IN USE

An actual exchange.

HEAVY MODE YOU

Mechanism and PK comparison of phenylpiracetam vs nefiracetam, with non-English literature where relevant.

KODIAC LAB

Mechanism.

Phenylpiracetam (carphedon) is a phenylated derivative of piracetam with documented activity at NMDA, AMPA, GABA, and nicotinic acetylcholine receptors, plus dopamine and norepinephrine transporter modulation [1]. Nefiracetam acts more selectively on AMPA-mediated long-term potentiation and shows nicotinic acetylcholine receptor sensitization at low doses [2]. Both modulate glutamatergic signaling, but the receptor breadth diverges materially.

Pharmacokinetics.

Phenylpiracetam plasma half-life is reported at 3 to 5 hours with rapid absorption [3]. Nefiracetam shows a longer functional half-life of approximately 5 to 8 hours and slower onset, with cumulative effects reported across multi-week dosing [2].

Receptor targets.

Phenylpiracetam: NMDA, AMPA, GABA-A, nAChR, DAT, NET. Nefiracetam: AMPA (positive allosteric modulation), nAChR sensitization, weaker GABA-A modulation. The phenyl substitution on phenylpiracetam adds the monoamine transporter activity that distinguishes the stimulant-leaning profile.

Notable differences.

Phenylpiracetam reads as a stimulant-adjacent nootropic with measurable acute output: faster reaction time, increased motor activation, modest dopaminergic load. Nefiracetam reads as a slower cognitive-load tool with cumulative working-memory effects and a cleaner side-effect profile in published studies. Tolerance develops faster on phenylpiracetam.

Stack considerations.

Pairing the two is documented in non-English nootropic literature but rarely with rigorous controls. The shared AMPA modulation creates redundancy. The unique-to-phenylpiracetam monoamine activity creates an additive risk if combined with other dopaminergic compounds.

Sources
  • [1] phenylpiracetam_carphedon_review_2019.pdf · p.7
  • [2] nefiracetam_ampa_ltp_2003.pdf · p.12
  • [3] phenylpiracetam_pk_human_2018.pdf · p.4
13 · NOT A GENERAL CHATBOT

Built for the work, not the lowest common denominator.

General AI Kodiac Lab
Mechanism depthSurface-level summariesReceptor subtype, dose-response, PK/PD
CitationsRare or noneEvery claim cited to your library
PosturePatient-directedInvestigator-directed (RUO)
LibraryNoneYour private indexed corpus
Compound profilesNoneAuto-generated, editable
Non-English literatureRarely surfacedMined when relevant
Vendor and protocol recordsNoneBuilt in
Compare toolNoneSide by side with diff summary
INTERNAL TODAY · PUBLISHED LATER

Every file, note, and compound has a visibility flag: private or published. The platform is built first for private research workflows. A published-research layer is planned for verified Kodiac customers. Your private corpus stays private.

Get early access.

Existing Kodiac customers are prioritized. Use the email on your most recent Kodiac order to skip the queue. New researchers welcome.